(Press Release) MabGenesis and Nippon Soda announce collaboration to discover and develop novel monoclonal antibodies for canine and feline use

MabGenesis Inc. and Nippon Soda Co., Ltd. today announced collaboration to discover and develop novel therapeutic monoclonal antibodies for canine and feline use. Please see the joint press release here.